Outlook Therapeutics, Inc. Skyrocketed
Fri, Mar 15, 2024 at 07:15 PM
Outlook Therapeutics, Inc. (OTLK:NASDAQ) shot up at $8.24, a gain of 43.8%. On Fri, Mar 15, 2024, OTLK:NASDAQ hit a New 2-Week High of $8.24. The stock got featured on our News Catalysts scanner on Tue, Mar 12, 2024 at 11:28 AM in the 'SPLIT' category. From Fri, Mar 01, 2024, the stock recorded 50.00% Up Days and 9.09% Green Days
The stock spiked on Fri, Mar 15, 2024 at $10.72 with a volume of 2M+.
About Outlook Therapeutics, Inc. (OTLK:NASDAQ)
Oncobiologics Inc is a clinical stage biopharmaceutical company. It is focused on identifying, developing, manufacturing and commercializing complex mAb therapeutics. The company has introduced BioSymphony Platform to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.
Top 10 Gainers:
- Verb Technology Company, Inc. (VERB:NASDAQ), 215.86%
- Geron Corporation (GERN:NASDAQ), 92%
- LianBio (LIAN:NASDAQ), 83.05%
- Cardlytics, Inc. (CDLX:NASDAQ), 77.15%
- JetAI Inc Com (JTAI:NASDAQ), 59.72%
- Chijet Motor Company Inc. (CJET:NASDAQ), 52.17%
- Canoo Inc. (GOEV:NASDAQ), 48.09%
- P3 Health Partners Inc. (PIII:NASDAQ), 44.33%
- Outlook Therapeutics, Inc. (OTLK:NASDAQ), 43.8%
- Veritone, Inc. (VERI:NASDAQ), 42.12%